El objeto del contrato viene determinado por el suministro del suministro de los principios activos denominados"Mirikizumab 100 mg/1ml pluma precargada subcutanea (OMVOH)" "Mirikizumab 300 mg vial 15 mlintravenosa (OMVOH)" Y "Selpercatinib 40 mg capsula oral

Contract type	Supplies
CPV	33690000
Awarded to	LILLY, S.A.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.